CTNM

NASDAQStock

Contineum Therapeutics, Inc. Class A Common Stock

$13.11-0.75 (-5.41%)

52-Week Range

$3.40
$16.00

Key Stats

Market Cap

478.9M

P/E Ratio

Dividend Yield

Beta

1.08

Volume

152.2K

Avg Volume

234.0K

Performance

1M

-4.02%

3M

+19.69%

6M

+16.72%

YTD

+21.69%

1Y

+96.32%

3Y

-10.00%

5Y

-10.00%

Price Chart

ETF Exposure

CTNM is held by 18 ETFs

ETFFund NameWeight
IWCiShares Micro-Cap ETF0.05%
IBBiShares Biotechnology ETF0.03%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.03%
IBBQInvesco Nasdaq Biotechnology ETF0.03%
BIBProShares - Ultra Nasdaq Biotechnology0.02%
AVSCAvantis U.S. Small Cap Equity ETF0.02%
SCHASchwab U.S. Small-Cap ETF0.01%
AVTMAvantis Total Equity Markets ETF 10.00%
VXFVanguard Extended Market ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
DFASDimensional - US Small Cap ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%

About CTNM ETF Exposure

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is held by 18 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 478.9M, CTNM is a widely held institutional stock. The stock currently trades at $13.11. Investors can gain exposure to CTNM through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CTNM, sorted by portfolio weight.